Skip to content
All news
General

3 Reasons Retirees Should Reconsider Standalone Medicare Drug Plans in 2026

As the Inflation Reduction Act fully takes effect in 2026, retirees face changes in premiums and surcharges for standalone Part D drug plans, prompting a fresh look at their options.

May 26, 2026
2 min read
Source: 24/7 Wall St.
Share:

When you turn 65 and sign up for Medicare, a wall of mail arrives pushing standalone Part D drug plans. For decades, the default move has been to pick one and forget it. For 2026, that default deserves a fresh look.

Key Changes in 2026

The Inflation Reduction Act fully kicks in this year, shifting premiums and surcharges. Meanwhile, bundled Medicare Advantage plans may offer more comprehensive coverage.

1. Rising Premiums and Surcharges

Standalone Part D plans may see increased monthly premiums, plus income-related surcharges for higher earners. This makes bundled plans more cost-effective.

2. Limited Coverage vs. Bundled Plans

Medicare Advantage (Part C) plans often include drug coverage plus extras like vision and dental, potentially eliminating the need for a separate Part D plan.

3. Pharmacy Network Changes

Some standalone Part D plans restrict pharmacy networks or charge more for out-of-network drugs, affecting those who rely on pharmacies like Costco.

What This Means for Retirees

Retirees should carefully compare standalone Part D plans with Medicare Advantage options, focusing on total cost and specific drug coverage. Use the Medicare.gov plan finder before the enrollment deadline.

Frequently Asked Questions

The Inflation Reduction Act is a U.S. law fully effective in 2026 that changes Medicare drug plan premiums and surcharges, potentially increasing costs for standalone Part D plans.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.